These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Advances in chemotherapy of non-small cell lung cancer. Molina JR; Adjei AA; Jett JR Chest; 2006 Oct; 130(4):1211-9. PubMed ID: 17035458 [TBL] [Abstract][Full Text] [Related]
5. Phase II studies with carboplatin in non-small cell lung cancer. Gatzemeier U; Heckmayr M; Neuhauss R; Hossfeld D; Achterrath W; Lenaz L Semin Oncol; 1990 Feb; 17(1 Suppl 2):25-31. PubMed ID: 2154856 [TBL] [Abstract][Full Text] [Related]
6. A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC). Raez LE; Santos ES; Webb RT; Wade J; Brito RA; Karr M; Kennah A; Childs BH Cancer Chemother Pharmacol; 2013 Nov; 72(5):1103-10. PubMed ID: 24057043 [TBL] [Abstract][Full Text] [Related]
7. Non-small-cell lung cancer: which platinum for gemcitabine? Boni C; Zanelli F; Ambroggi M; Bologna A Ann Oncol; 2006 May; 17 Suppl 5():v79-81. PubMed ID: 16807470 [No Abstract] [Full Text] [Related]
8. Novuspharma announces preliminary results of phase II trials for BBR 3464. Expert Rev Anticancer Ther; 2001 Oct; 1(3):325-6. PubMed ID: 12113097 [No Abstract] [Full Text] [Related]
9. Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma. Bleehen NM; Ball D; Belani CP; Bishop J; Douillard JY; Cox JD; Johnson DH; Le Chevalier T; Saunders MI; Shaw E Lung Cancer; 1994 Mar; 10 Suppl 1():S19-23. PubMed ID: 8087510 [No Abstract] [Full Text] [Related]
10. [Use of dicarbamin in platinum-containing chemotherapy of lung cancer]. Nekrasova OV; Shanazarov NA; Chertov EA; Zhusupova BT Vopr Onkol; 2011; 57(3):366-8. PubMed ID: 21882609 [No Abstract] [Full Text] [Related]
11. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer]. Kawahara M Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104 [TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced non small-cell lung cancer in the elderly: from best supportive care to the combination of platin-based chemotherapy and targeted therapies. Gridelli C J Clin Oncol; 2008 Jan; 26(1):13-5. PubMed ID: 18165633 [No Abstract] [Full Text] [Related]
13. New platinum derivatives in advanced non-small cell lung cancer. Crinò L; Cappuzzo F Suppl Tumori; 2002; 1(4):S24-5. PubMed ID: 12415810 [No Abstract] [Full Text] [Related]
14. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A]. Mornex F Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239 [No Abstract] [Full Text] [Related]
15. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer. Belani CP Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542 [TBL] [Abstract][Full Text] [Related]